Synthetica Pioneering Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Synthetica Pioneering Co., Ltd. - overview
Established
2023
Location
Shenzhen, Guangdong, China
Primary Industry
Biotechnology
About
Founded in 2023, and based in Shenzhen, China, Synthetica Pioneering Co. , Ltd. is a company that focuses on the research and development of live bacterial drugs for the treatment of solid tumors. In July 2024, it closed a series A funding led by new investors Boehringer Ingelheim Venture Fund.
Synthetica Pioneering Co. , Ltd. is committed to the research and development of live bacterial drugs and anti-tumor live bacterial drugs. The company generates revenue by developing live bacterial drugs for the treatment of solid tumors.
The funds will be used to accelerate the company's oncolytic bacterial pipelines into clinical trials.
Current Investors
Temasek Holdings, Boehringer Ingelheim Venture, Lenovo Capital and Incubator Group
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.